QUIDEL QUICKVUE® INFLUENZA A+B TESTS

Diagnosing influenza can be confusing. One third of all upper respiratory infections are caused by influenza. This leads to over 36,000 deaths, 200,000 hospitalizations and accounts for over $12 billion spent in lost work and related medical expenses each year in the U.S.

Quidel’s CLIA-waived QuickVue® Influenza A+B test provides you with differential A or B test results allowing you to test and treat in just one visit.

Prompt type-specific diagnosis enables a choice of antiviral therapy, helps avoid the overuse of antibiotics, and prevents healthcare costs related to unnecessary testing and treatment.

The QuickVue® Influenza A+B test has also been shown to detect cultured avian influenza viruses, including avian Influenza A subtype H5N1 virus; however, as with other rapid tests for influenza, the ability of the QuickVue® Influenza A+B test to detect influenza Type A in patients infected with H5N1 has not been established.

The QuickVue® Influenza A+B test is CLIA waived, sensitive and specific, giving you the results you need.

Right. Now. Rapid Diagnosis and Treatment

Identifies influenza Type A or B in positive samples, in about 10 minutes, for better patient management decisions. Most patients tested can be diagnosed and treated in just one visit.

Accurate Detection

QuickVue® Influenza A+B test detects both types A and B viral antigens. Accurate detection with nasal swab samples: 94% sensitivity and 90% specificity for type A 74% sensitivity and 97% specificity for type B

Easy to Use 3 steps 1 reagent, 90 seconds hands-on time. 1 test procedure provides results for both A and B. Convenient Packaging Each kit contains everything needed to perform the test, including foam-tipped nasal swabs and Positive and Negative Controls. Available in 25-test kit. Room temperature storage with 24-month shelf life from date of manufacture. Transport swab set also available separately.

Be the first to rate this product!